Average Co-Inventor Count = 8.83
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (40 from 123 patents)
2. Cancer Research Technology Limited (7 from 262 patents)
3. The Institute of Cancer Research: Royal Cancer Hospital (7 from 51 patents)
4. Otsuka Pharmaceutical Company, Limited (3 from 846 patents)
43 patents:
1. 11939321 - Benzolactam compounds as protein kinase inhibitors
2. 11001575 - Benzolactam compounds as protein kinase inhibitors
3. 10519137 - Pyrazolyl quinoxaline kinase inhibitors
4. 10457669 - Benzolactam compounds as protein kinase inhibitors
5. 10272087 - Pteridines as FGFR inhibitors
6. 10052320 - Substituted quinoxalines as FGFR kinase inhibitors
7. 10045982 - Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
8. 10039759 - Quinolines as FGFR kinase modulators
9. 9856236 - Substituted quinoxalines as FGFR kinase inhibitors
10. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
11. 9464071 - Pyrazolyl quinoxaline kinase inhibitors
12. 9447098 - Pteridines as FGFR inhibitors
13. 9439896 - Quinolines as FGFR kinase modulators
14. 9309242 - Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
15. 9303029 - Substituted quinoxalines as FGFR kinase inhibitors